Physician

Samuel J Pruden, MD

According to 2025 Medicare claims, Samuel Pruden, MD (NPI: 1871593996) practices dermatology in the Lexington-Fayette, KY market, with the plurality of this provider's patient population coming from Fayette, KY. This provider's primary affiliated billing organization is REGIONAL DERMATOLOGY PLLC (NPI: 1255851200; TIN: 464901353) and primary practice location at 40513-1175.

Pruden's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 13,171 HCPCS/CPT codes, and received $296,387 in Medicare payments. The top billing code was 99203 (New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more). Part D data shows 397 prescription claims across 201 beneficiaries totaling $169,837 in drug costs, led by Erivedge (Vismodegib). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $87,447 to $296,387. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $17,343 and ending at $169,837. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$148K$296K2015 Medicare payment: $87,447 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $95,833 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $98,927 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $129,839 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $142,625 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $91,181 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $111,019 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $131,069 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $158,378 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $296,387 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20154191,494$87,447
20164601,943$95,833
20173851,646$98,927
20182741,391$129,839
20192661,570$142,625
20201671,069$91,181
20211971,251$111,019
20222161,674$131,069
20232226,880$158,378
202423513,171$296,387

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$85K$170K2015 Drug cost: $17,343 (USD; Tot_Drug_Cst)2016 Drug cost: $47,684 (USD; Tot_Drug_Cst)2017 Drug cost: $133,415 (USD; Tot_Drug_Cst)2018 Drug cost: $29,744 (USD; Tot_Drug_Cst)2019 Drug cost: $43,788 (USD; Tot_Drug_Cst)2020 Drug cost: $40,658 (USD; Tot_Drug_Cst)2021 Drug cost: $15,779 (USD; Tot_Drug_Cst)2022 Drug cost: $9,993 (USD; Tot_Drug_Cst)2023 Drug cost: $81,893 (USD; Tot_Drug_Cst)2024 Drug cost: $169,837 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015105218$17,343
2016115212$47,684
2017153361$133,415
2018145348$29,744
2019159348$43,788
2020163322$40,658
2021185380$15,779
2022184350$9,993
2023194384$81,893
2024201397$169,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more7373$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more136242$58
17000Destruction of precancer skin growth, 1 growth103139$32
88305Pathology examination of tissue using a microscope, intermediate complexity95203$27
17003Destruction of precancer skin growth, 2-14 growths71391$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ErivedgeVismodegib11330$160,705
FluorouracilFluorouracil28638$2,219
Hydroxychloroquine SulfateHydroxychloroquine Sulfate24840$836
FluocinonideFluocinonide22645$672
Triamcinolone AcetonideTriamcinolone Acetonide331,304$609

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Samuel J. Pruden, MD?

Tedicare shows public-source Medicare data for Samuel J. Pruden, MD (NPI 1871593996), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samuel J. Pruden, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samuel J. Pruden, MD?

Samuel J. Pruden, MD is linked to REGIONAL DERMATOLOGY PLLC (billing NPI 1255851200) in the available physician profile data.

Does Samuel J. Pruden, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.